| Literature DB >> 30233263 |
Mario Miniati1, Antonio Callari1, Alessandra Maglio1, Simona Calugi2.
Abstract
BACKGROUND: Interpersonal psychotherapy (IPT) is a time-limited and affect-, life-event-, and present-focused psychotherapy originally conceptualized for unipolar depression, and then adapted to the treatment of other disorders, including eating disorders (EDs). The purpose of this paper is to conduct a systematic review of studies on IPT for EDs.Entities:
Keywords: anorexia nervosa; binge-eating disorder; bulimia nervosa; eating spectrum; interpersonal psychotherapy; treatment efficacy
Year: 2018 PMID: 30233263 PMCID: PMC6130260 DOI: 10.2147/PRBM.S120584
Source DB: PubMed Journal: Psychol Res Behav Manag ISSN: 1179-1578
Studies on IPT for eating disorders
| Authors | Patients | Design | Selection criteria | Outcome measures | Interventions | Results |
|---|---|---|---|---|---|---|
| McIntosh et al | 56 | Randomized study (IPT vs CBT vs NSSCM. | AN-R (DSM-IV) | EDE, HAM-D, GAF, EDI-2. | Twenty sessions conducted over a minimum of 20 weeks. | IPT was found to be the least effective of the three treatments. |
| Carter et al | 35/56 | 5-year follow-up. | Completers from McIntosh study (2005). | EDE, HAM-D, GAF, EDI-2. | Patients receiving vs not receiving any treatment for eating difficulties over the follow-up period. | Participants initially randomized to IPT (who had the poorest global outcome rating at posttreatment) showed the “best global outcome rating” at long-term follow-up. |
| McIntosh et al | 53/56 | Adherence study for 53 of 56 female patients already randomized in the McIntosh study (2005). | AN-R (DSM-IV) | CSPRS: adherence to specific treatments. | Twenty sessions conducted over a minimum of 20 weeks. Selection of three sessions, across the three therapy phases. | The three forms of psychotherapy were distinguishable by blind raters. Subscale scores were higher for the corresponding therapy than the other therapy modalities. |
| Fairburn et al | 75 | Randomized controlled study (CBT-BN vs BT vs IPT). | BN (DSM-IV). | Main outcome measure: binging/purging frequency at therapy end | Eighteen manual-based sessions conducted over 19 weeks. | CBT-BN significantly more effective in reducing “dysmorphophobic symptoms” and “resorting to overly drastic diets” than IPT. |
| Fairburn et al | 75 | 12-month follow-up. | Completers of previous study (BN DSM-IV criteria). | 4-, 8-, and 12-month evaluation with EDE. | No administration of therapies. | No differences between CBT-BN and IPT over the 8 months following treatment. |
| Jones et al | 38/75 | Same sample of Fairburn studies. | Completers of all the 1-year FU evaluations. | EAT-40, BDI, RSE, and a form for the assessment of binge eating, vomiting, and laxative abuse. | No administration of therapies. | Early decrease (weeks 1–4) in the frequency of binge eating in all three treatments. In IPT, there was little change thereafter, whereas in BT and CBT the decrease continued until around Week 8 and then the rate stabilized. Statistically significant improvement in self-esteem over time. No clues as to the mechanism of action of IPT. |
| Fairburn et al | 89/99 | 6-year follow-up. | Ninety-nine patients with BN (DSM-IV) initially randomized to CBT-BN vs BT vs IPT; 89 reevaluated after 6 years. | DSM-IV diagnostic assessment at baseline and after 6 years. | No administration of therapies, except for patients with severe needs. | Forty-six percent of the sample still satisfied DSM-IV criteria for an ED. Patients who received CBT-BN or IPT were doing markedly better than those who had received BT. |
| Agras et al | 220 | Randomized multicenter controlled study (CBT-BN vs BT vs IPT). | BN (DSM-III-R). | EDE before and after treatment, and at 4-, 8-, and 12-month follow-up. | Twenty weeks of treatment; 1-year follow-up. | CBT-BN was found to be superior to IPT at the end of treatment. By 8–12 months open follow-up, the two treatments were equivalent. |
| Wolk and Devlin | 110/129 | Randomized, multicenter study CBT-BN vs IPT. | DSM-III-R criteria for BN. | State of Change Scale (SOC) to predict outcome. | Nineteen sessions of treatment. | SOC was a weakly significant predictor of improvement only for IPT. No significant association was found for CBT-BN group. |
| Constantino et al | 220 | Patients drawn from the Agras multicenter RCT. | DSM-III-R criteria for BN. | EDE, Expectation of Improvement and Suitability of Treatment Form, IIP, HAq, Purge Frequency Form. | Twenty weeks of treatment; 1-year follow-up. | Relationship between specific patient characteristics and the development of the alliance. In CBT, baseline symptom severity was negatively related to middle alliance. In IPT, more baseline interpersonal problems were associated with poorer alliance quality at mid-treatment. |
| Costantino and Smith-Hansen | 220 | Patients drawn from the Agras multicenter RCT. | BN (DSM-IV). | II-P, HAq (an 11-item self-report measures assessing alliance quality from the patients’ perspective). | Twenty weeks of treatment; 1-year follow-up. | Early and middle alliance negatively associated with interpersonal distress and positively associated with interpersonal affiliation. Middle alliance was related to treatment group interactions with rigidity, affiliation, and control. Alliance growth was higher in IPT than in CBT. |
| Arcelus et al | 59 | Case series evaluation of a modified form of IPT for the treatment of BN | BN or EDNOS (DSM-IV). | SCL-90, RSE, EDE-Q, IIP-32 and BDI, at baseline. EDE-Q, IIP-32, and BDI. | Sixteen weekly 45 minutes sessions. Evaluations at middle and treatment end. | By the middle of therapy, improvements in terms of reductions in EDE-Q scores, binging and self-induced vomiting, interpersonal functioning and depression. |
| Arcelus et al | 30 | Pilot study. Comparison between IPTBN-10 and patients who already received IPT-BN or in Waiting List condition | DSM-IV criteria for BN and EDNOS with bulimic features, including BED. | BITE, EDE-Q, BDI. | Ten 45 minutes sessions, usually conducted on a weekly basis. | No significant difference was found between the groups for the presence of binging and vomiting, and not on any of the EDE-Q scales when comparing IPT-BN10 and IPT-BN. |
| Serpell et al | 98 | Retrospective study. | BN/EDNOS BN-subtype. | BTHQ developed for the study. | One session: participants asked to answer to BTHQ. | No useful information of IPT: only three patients were treated with this psychotherapy. |
| Fairburn et al | 130 | RCT on CBT-E vs IPT. | DSM-IV diagnoses of BN, BED, and “other EDs”. | EDE; CIA; SCID-IV; BDI. | 20–50 minutes sessions; review 20 weeks after treatment; then, 60-week follow-up. | Changes significantly greater for CBT-E. 75.5% of CBT-E patients achieved remission, compared with 37.7% of IPT patients. Posttreatment differences between CBT-E and IPT were no longer statistically significant at 60 weeks. |
| Cooper et al | 130 | Same sample and initial design of the Fairburn study (2015). | BN, BED, and “other EDs” according to DSM-IV. | RSE; SCID-IV; SAS; EDE. | Potential predictors and then moderators identification. | At 60-week follow-up, patients with low levels of self-esteem at baseline responded better to CBT-E than to IPT. |
| Gomez Penedo et al | 220 | RCT (sample of Agras study) CBT-BN vs BT vs IPT. | BN (DSM-III-R). | IIP (127 items); IIP-C (64 items); EDE; SCID-III-R. | Focus on interpersonal problems at baseline as predictors of purge at 12 months after completion. | The more baseline problems were relevant the more patients were likely to recover when treated with IPT vs CBT. |
| Wilfley et al | 56 | Randomized controlled study (group CBT vs group IPT vs controls in WL). 1-year follow-up. | Nonpurging bulimia. | EDE, BMI. | Twelve weeks treatment with group CBT 12 weeks treatment with group IPT. | Both group CBT and group IPT had a significant improvement in reducing BED but not for WL. BED significantly below baseline levels for both treatments at 6-month and 1-year follow-up. |
| Agras et al | 50 | Quasi-experimental study Nonresponders to group CBT assigned to group IPT vs WL. | BED. | Frequency of binge eating; BDI; BES; SCL-90; RSE; TFEQ. | 12 weeks group CBT. 12 weeks group IPT. | IPT/CBT both reduced binge eating and weight significantly more than the WLC. No further improvement with IPT for patients who did not improve with CBT. |
| Wilfley et al | 162 | Randomized controlled study Group CBT vs group IPT. | BED (DSM-III-R). | EDE, BMI, Rosemberg Self-Esteem and Social Functioning, IIP, SAS. | Twenty weekly 90 minutes group IPT sessions and three individual sessions. | Similar outcomes in remission rates (64% vs 59%), at the end of treatment and at 1-year follow-up. Dietary restriction improvement more rapid in CBT. |
| Wilson et al | 205/470 | Randomized controlled study IPT vs BWL vs CBTgsh 24-week interval, 2 year follow-up. | BED (DSM-IV). | Individual 50–60 minutes long sessions (except for the first, which lasted for 2 hours). Nineteen sessions during 24 weeks. | No differences on the EDE subscales or for BDI or self-esteem scale. BWL >IPT and CBTgsh on BMI, and >CBTgsh in increasing dietary restraint. At 1 year, no significant differences were seen. | |
| Sysko et al | 205 | Sample derived from the Wilson RCT. | BED (DSM-IV). | Latent class analysis to evaluate subgroups within the population of BED patients. | Individual 50–60 minutes sessions; 19 sessions during 24 weeks. | DSM-IV criteria may not sufficiently address the heterogeneity within this diagnosis. |
| Hilbert et al | 90 | RCT on CBT vs IPT (group) 4 year follow-up. | BED (DSM-IV-TR). | EDE, EDE-Q, depression and anxiety subscales of the BSI. | Twenty weekly 90 minutes group sessions and three additional individual sessions. | Abstinence from binge eating stable over the follow-up period in the IPT group; significant tendency to relapse among patients in the CBT group. |
| Hilbert et al | 205 | RCT on IPT, CBTgsh, and BWT to compare the three treatments on the short term and the long term. | BED (DSM-IV). | EDE; number of objective binge-eating episodes over the past 28 days. | 24-week period; assessment both at post treatment, and at 6, 12, 18, and 24 months. | Rapid response in 70% of study participants (145/205); no differences among the three treatment groups. Rapid responders in BWL did not differ from non-rapid responders in CBTgsh and IPT. |
| Tanofsky-Kraff et al | 113 | Pilot study with IPT-WG; then RCT and 1–3-year follow-up. | Overweight adolescents (12–17 years). | BMI, EDE at baseline, 6 months, and 1 year. | Focus Group and general reactions to IPT-WG. | Program generally well accepted by both adolescents and parents. |
| Cassidy et al | 44 | Community-based research with focus groups after IPT-WG. | Overweight adolescents (12–17 years). | BMI, EDE-Q. | Individual 1.5-hours meeting followed by 12 consecutive weekly 90 minutes group sessions. HE was based on the HEY-Durham manual for high-school students. | Decreases in BMI gain, age-adjusted BMI metrics, symptoms of depression and anxiety, and frequency of LOC eating over 12 months FU with no group differences. In follow-up analyses, IPT was more efficacious than HE at reducing objective binge eating at the 12-month follow-up. |
| Tanofsky-Kraff et al | 113/116 | RCT with 60 patients randomly assigned to health education and 56 patients to IPT. Three patients excluded after randomization. | Overweight adolescents (12–17 years) between 75th and 97th percentile and at least one LOC episode during the last month. | BMI, binge episodes, LOC episodes, EDE, SAS, BDI, STAIC. | IPT-WG group sessions vs a health education program. | Relationship between adolescent girls’ interpersonal problem area and depressive symptoms was not entirely accounted for by individual differences in alexithymia. |
| Berger et al | 56 | Sample drawn from the Tanofsky-Kraff RCT, randomized to IPT-WG or health education program. | Adolescent girls (12–17 years) between 75th and 97th percentile. | Anthropometrics, EDE, BDI, TAS-20. | Individual 1.5 hours meeting followed by 12 consecutive weekly 90 minutes group sessions. | IPT did not change total intake at the test meal and was associated with reduced snack-food intake. |
| Tanofsky-Kraff et al | 88/113 | Sample drawn from a previous RCT with 60 patients randomly assigned to health education and 56 patients to IPT. | Overweight adolescents (12–17 years) between 75th and 97th percentile and at least one LOC episode during the last month. | Anthropometrics, EDE, Brunel Mood Scale for pre-meal negative affect, Buffet Test Meal. | HE was based on the HEY-Durham manual for high-school students. | There was no significant group difference for changes in total intake relative to girls’ daily energy needs. |
| Tanofsky-Kraff et al | 1 | Brief case study. | Case report on a 13-year-old girl. | IPT-WG group sessions. | Successful example of IPT-WG for the prevention of excessive weight gain and for the prevention of BED. | |
| Burke et al | 68 | Secondary analyses on the same sample of the Tanofsky-Kraff study. | Overweight adolescents (12–17 years). | BMI, EDE. | Adapted version of IPT or a HE comparison group. | Older patients in IPT with the lowest 3-year BMI gain compared to younger ones in both conditions and older girls in HE. Non-White girls in IPT-WG more likely to abstain from LOC eating at 3 years. |
| Tanofsky-Kraff et al | 88/113 | Sample from a previous RCT recontacted 3 years after the initiation of the group programs. | Overweight adolescents (12–17 years). | EDE, SAS, STAIC; CBCL. | Approximately 3 years following the initiation of the group programs, girls were recontacted with an additional assessment. | No main effect of group on change in BMI/adiposity. Among girls with high self-reported baseline social adjustment problems or anxiety, IPT, compared with HE, was associated with the steepest declines in BMI. For adiposity, girls with high or low anxiety in HE, and girls with low anxiety in IPT experienced gains, while girls in IPT with high anxiety stabilized. |
| Shomaker et al | 29 | Randomized, comparison pilot trial on feasibility and acceptability of FB-IPT. | Preadolescents, 8–13 years overweight, obese, LOC. | Completers evaluated post follow-up – after 6 and 12 months. | Twelve weekly, 45 minutes sessions delivered to parents and children vs HE program. | FB-IPT was well accepted by both patients and relatives. |
| Mitchell et al | 62 | Randomized multicenter study: IPT vs fluoxetine/desipramine after CBT-BN. | DSM-IV patients with BN who failed the first treatment with CBT-BN. | Abstinence from purging. | Twenty sessions over 16 weeks. | The dropouts were frequent: of the 62 patients randomized to the second-line treatment, 37 completed while 25 dropped out or were withdrawn. The abstinence rates for subjects assigned to both second-line treatments were low: 16% for IPT and 10% for those assigned to medication management. |
| Hendricks and Thompson | 1 | Case report. | DSM-IV patient with BN, depression, and alcohol abuse (CBT-BN and IPT). | Abstinence from purging. | Four stages of treatment (IPT at stage IV). | The patient stopped binge eating, but she continued to vomit. |
| Nevonen et al | 29 | Pilot study (group CBT followed by group IPT). | DSM-IV BN and EDNOS; BMI >18. | EDI-2, SCL-90, CRI, BDI, and BMI. | Twenty sessions over a period of 20 weeks. 1-year follow-up. | Self-ratings showed significant differences between pretreatment and follow-up. Compared with pretreatment, a significant decrease in the 1-year follow-up scores was found on interpersonal distrust, social insecurity, and interpersonal sensitivity. |
| Nevonen and Broberg | 138 | Randomized controlled study 2.5-year follow-up GRP vs IND. | DSM-IV BN and EDNOS; BMI >18. | RAB, EDE, CEDRI, EDI-2, IIP, SCL-90, BDI, BMI. | Sequenced GRP: Twenty-three 2-hour sessions over a period of 20 weeks. | The 2.5-year follow-up intention-to-treat analysis showed a stabilized recovery rate for GRP and increased recovery from the 1-year to the 2.5-year follow-up for IND. Logistic regression analyses showed no significant effects of medication on recovery between IND and GRP at posttreatment or follow-up assessments. |
Abbreviations: AN, anorexia nervosa; BDI, Beck Depression Inventory; BED, binge eating disorder; BES, Binge Eating Scale; BITE, Bulimic Investigatory Test Edinburgh; BMI, body mass index; BMS, Brunel Mood Scale; BN, bulimia nervosa; BSI, Brief Symptom Inventory; BTHQ, Bulimia Treatment History Questionnaire; BWL, behavioral weight loss; CBCL, Child Behavior Checklist; CBT-BN, cognitive-behavioral therapy for bulimia nervosa; CBT-E, enhanced version of cognitive-behavioral therapy; CBTgsh, guided self-help based on cognitive behavior therapy; CEDRI, Clinical Eating Disorder Rating Instrument; CIA, Clinical Impairment Assessment Questionnaire; CRI, Coping Resources Inventory; CSPRS, Collaborative Study Psychotherapy Rating Scale; EDE, Eating Disorder Examination; EDE-Q, Eating Disorder Examination Questionnaire; EDI-2, Eating Disorder Inventory-2; ED-NOS, eating disorder not otherwise specified; SCID-IV, Structured Clinical Interview for DSM-IV; GAF, Global Assessment of Functioning; GRP, sequenced group treatment; HAM-D, Hamilton Rating Scale for Depression; HAq, 11-item self-report measures assesses alliance quality from the patients’ perspective; IIP, Inventory of Interpersonal Problems; IIP-32, Short Version of the Inventory of Interpersonal Problems; IND, sequenced individual treatment; IPT, interpersonal psychotherapy; IPT-WG, IPT weight gain; LOC, loss of control eating; NSSCM, nonspecific supportive clinical management; RAB, Rating of Anorexia and Bulimia interview; RCT, randomized controlled trial; RSE, Rosemberg Self-Esteem and Social Functioning; SAS, Social Adjustment Scale; SCL-90, Symptom Checklist-90; SOC, State of Change Scale; STAIC, State-Trait Anxiety Inventory for Children-A Trait Scale; TAS-20, Toronto Alexithymia Scale; TFEQ, Three-Factor Eating Questionnaire; WL, waiting list; WLC, waiting list condition.
Research clinical trials on IPT for EDs: RCT of Psychotherapy Quality Rating Scale scoring
| Fairburn et al | Wilfley et al | Agras et al | Wilfley et al | Mitchell et al | McIntosh et al | Nevonen and Broberg | Wilson et al | Tanofsky-Kraff et al | Fairburn | |
|---|---|---|---|---|---|---|---|---|---|---|
|
| ||||||||||
| 1. Diagnostic method and inclusion/exclusion criteria | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| 2. Documentation/demonstration of reliability of diagnostic methodology | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| 3. Description of relevant comorbidities | 2 | 0 | 2 | 2 | 2 | 1 | 0 | 2 | 1 | 2 |
| 4. Description of number of patients screened, included, and excluded | 2 | 0 | 2 | 2 | 2 | 1 | 2 | 2 | 2 | 2 |
|
| ||||||||||
|
| ||||||||||
| 5. Treatment(s) (including control/comparison groups) are sufficiently described or referenced to allow for replication | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| 6. The treatment being studied is treatment delivered | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| 7. Therapist training/level of experience in treatment(s) under investigation | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| 8. Therapist supervision while treatment is being provided | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| 9. Description of concurrent treatments allowed and administered | 2 | 2 | 2 | 0 | 0 | 1 | 1 | 0 | 1 | 2 |
|
| ||||||||||
|
| ||||||||||
| 10. Validated outcome measure(s) | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| 11. Primary outcome measure(s) specified in advance | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| 12. Outcome assessment by raters blinded to treatment group and with established reliability | 2 | 2 | 2 | 2 | 0 | 2 | 2 | 2 | 2 | 2 |
| 13. Discussion of safety and adverse events during study treatment(s) | 2 | 0 | 0 | 2 | 0 | 1 | 0 | 0 | 0 | 1 |
| 14. Assessment of long-term post-termination outcome | 0 | 2 | 0 | 2 | 2 | 0 | 2 | 2 | 2 | 2 |
|
| ||||||||||
|
| ||||||||||
| 15. Intent-to-treat method for data analysis, primary outcome | 0 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| 16. Description of dropouts and withdrawals | 2 | 0 | 2 | 2 | 2 | 1 | 2 | 2 | 2 | 1 |
| 17. Appropriate statistical tests | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| 18. Adequate sample size | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| 19. Appropriate consideration of therapist and site effects | 2 | 2 | 2 | 2 | 2 | 1 | 0 | 2 | 2 | 2 |
|
| ||||||||||
|
| ||||||||||
| 20. A priori relevant hypotheses that justify comparison group(s) | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| 21. Comparison group(s) from same population and timeframe as experimental group | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| 22. Randomized assignment to treatment groups | 2 | 2 | 2 | 2 | 2 | 1 | 2 | 2 | 2 | 2 |
|
| ||||||||||
|
| ||||||||||
| 23. Balance of allegiance to types of treatment by practitioners | 2 | 2 | 2 | 2 | 0 | 2 | 0 | 2 | 0 | 2 |
| 24. Conclusions justified by sample, measures, and data analysis | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| 25. Omnibus rating | 7 | 7 | 7 | 7 | 6 | 6 | 5 | 7 | 6 | 7 |
Abbreviations: ED, eating disorder; IPT, interpersonal psychotherapy; RCT, randomized controlled trial.
Long-term follow-up derived from sample randomized in RCTs on IPT for EDs: RCT of Psychotherapy Quality Rating Scale scoring
| 1. Diagnostic method and inclusion/exclusion criteria | 2 | 2 | 2 | 2 | 1 |
| 2. Documentation/demonstration of reliability of diagnostic methodology | 2 | 2 | 2 | 2 | 2 |
| 3. Description of relevant comorbidities | 1 | 2 | 0 | 1 | 1 |
| 4. Description of numbers of subjects screened, included, and excluded | 0 | 1 | 0 | 2 | 2 |
|
| |||||
|
| |||||
| 5. Treatment(s) (including control/comparison groups) are sufficiently described or referenced to allow for replication | 2 | 1 | 1 | 2 | 2 |
| 6. The treatment being studied is treatment delivered | 2 | 2 | 2 | 2 | 2 |
| 7. Therapist training and level of experience in the treatment(s) under investigation | 2 | 2 | 1 | 1 | 2 |
| 8. Therapist supervision while treatment is being provided | 2 | 2 | 2 | 2 | 2 |
| 9. Description of concurrent treatments allowed and administered | 2 | 0 | 1 | 1 | 0 |
|
| |||||
|
| |||||
| 10. Validated outcome measure(s) | 2 | 2 | 2 | 2 | 2 |
| 11. Primary outcome measure(s) specified in advance | 2 | 2 | 2 | 2 | 2 |
| 12. Outcome assessment by raters blinded to treatment group and with established reliability | 2 | 2 | 0 | 0 | 2 |
| 13. Discussion of safety and adverse events during study treatment(s) | 2 | 2 | 1 | 0 | 0 |
| 14. Assessment of long-term post-termination outcome | 2 | 2 | 2 | 2 | 2 |
|
| |||||
|
| |||||
| 15. Intent-to-treat method for data analysis, primary outcome | 0 | 0 | 2 | 2 | 0 |
| 16. Description of dropouts and withdrawals | 2 | 2 | 1 | 1 | 0 |
| 17. Appropriate statistical tests | 2 | 2 | 2 | 2 | 2 |
| 18. Adequate sample size | 2 | 2 | 1 | 2 | 2 |
| 19. Appropriate consideration of therapist and site effects | 2 | 2 | 0 | 0 | 0 |
|
| |||||
|
| |||||
| 20. A priori relevant hypotheses that justify comparison group(s) | 2 | 2 | 2 | 2 | 0 |
| 21. Comparison group(s) from same population and time frame as experimental group | 2 | 1 | 2 | 2 | 2 |
| 22. Randomized assignment to treatment groups | 2 | 2 | 1 | 2 | 2 |
|
| |||||
|
| |||||
| 23. Balance of allegiance to types of treatment by practitioners | 2 | 0 | 2 | 0 | 0 |
| 24. Conclusions justified by sample, measures, and data analysis | 2 | 2 | 2 | 2 | 2 |
| 25. Omnibus rating | 7 | 5 | 5 | 5 | 5 |
Notes: Main reports,
Fairburn et al,11
McIntosh et al,16
Wilfley et al,29
Tanofsky-Kraff et al.46
Abbreviations: ED, eating disorder; IPT, interpersonal psychotherapy; RCT, randomized controlled trial.
Figure 1PRISMA flow diagram of selection studies.14
Abbreviation: PRISMA, Preferred Reporting Items for Systematic Review and Meta-Analyses.